Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Teladoc Health, Inc.
Report date September 04, 2024 · Filed September 05, 2024
Section 16 reporting ended · disclosed 2024-09-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,773 |
Reported balance
After 2024-09-04 transaction · row 1
1 source rowRow 1 · 2024-09-04 · Sale · Disposed 20,773 · Balance 20,773 F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 4, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 4, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2020 Filed Mar 4, 2020 16:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 718 | $124.32 | $89,261.76 |
DisclosureSEC source: 0001179110-20-003089 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,572 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 16:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,304 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-003089 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:30 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 7,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002586 · edgar.xml · derivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,699 Underlying: Common Stock · 7,699 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F2 · shares: Performance award amount determined based on metrics in respect of the issuer's 2019 financial results. F3 · derivative.exercise_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. F3 · derivative.expiration_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,150 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-012586 · edgar.xml · derivative · entry 7 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,350 Underlying: Common Stock · 2,150 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,168 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-19-012586 · edgar.xml · derivative · entry 6 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,836 Underlying: Common Stock · 4,168 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,840 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-012586 · edgar.xml · derivative · entry 5 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,841 Underlying: Common Stock · 2,840 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 9,158 | $80.00 | $732,640.00 |
DisclosureSEC source: 0001179110-19-012586 · edgar.xml · nonDerivative · entry 4 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,986 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019. F2 · price: Represents the weighted average price of transactions ranging from $79.87 to $80.25. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,150 | $38.55 | $82,882.50 |
DisclosureSEC source: 0001179110-19-012586 · edgar.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,168 | $22.30 | $92,946.40 |
DisclosureSEC source: 0001179110-19-012586 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,840 | $12.21 | $34,676.40 |
DisclosureSEC source: 0001179110-19-012586 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 16:26 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,150 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-010238 · edgar.xml · derivative · entry 7 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,500 Underlying: Common Stock · 2,150 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 16:26 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,167 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-19-010238 · edgar.xml · derivative · entry 6 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,004 Underlying: Common Stock · 4,167 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 16:26 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,841 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-010238 · edgar.xml · derivative · entry 5 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,681 Underlying: Common Stock · 2,841 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 16:26 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 9,158 | $62.27 | $570,268.66 |
DisclosureSEC source: 0001179110-19-010238 · edgar.xml · nonDerivative · entry 4 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,986 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019. F2 · price: Represents the weighted average price of transactions ranging from $61.63 to $62.63. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 16:26 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,150 | $38.55 | $82,882.50 |
DisclosureSEC source: 0001179110-19-010238 · edgar.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 16:26 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,167 | $22.30 | $92,924.10 |
DisclosureSEC source: 0001179110-19-010238 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 16:26 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,841 | $12.21 | $34,688.61 |
DisclosureSEC source: 0001179110-19-010238 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,827 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,150 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-007875 · edgar.xml · derivative · entry 7 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,650 Underlying: Common Stock · 2,150 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,167 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-19-007875 · edgar.xml · derivative · entry 6 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,171 Underlying: Common Stock · 4,167 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,840 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-007875 · edgar.xml · derivative · entry 5 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,522 Underlying: Common Stock · 2,840 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 9,157 | $60.05 | $549,877.85 |
DisclosureSEC source: 0001179110-19-007875 · edgar.xml · nonDerivative · entry 4 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,986 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019. F2 · price: Represents the weighted average price of transactions ranging from $60.00 to $60.18. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,150 | $38.55 | $82,882.50 |
DisclosureSEC source: 0001179110-19-007875 · edgar.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,167 | $22.30 | $92,924.10 |
DisclosureSEC source: 0001179110-19-007875 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,840 | $12.21 | $34,676.40 |
DisclosureSEC source: 0001179110-19-007875 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2019 Filed Apr 8, 2019 17:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,600 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-004826 · edgar.xml · derivative · entry 7 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,800 Underlying: Common Stock · 8,600 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| April 04, 2019 Filed Apr 8, 2019 17:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,891 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-19-004826 · edgar.xml · derivative · entry 6 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,338 Underlying: Common Stock · 13,891 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| April 04, 2019 Filed Apr 8, 2019 17:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,469 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-004826 · edgar.xml · derivative · entry 5 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,362 Underlying: Common Stock · 9,469 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| April 04, 2019 Filed Apr 8, 2019 17:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 31,960 | $55.82 | $1,784,007.20 |
DisclosureSEC source: 0001179110-19-004826 · edgar.xml · nonDerivative · entry 4 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,986 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019. F5 · price: Represents the weighted average price of transactions ranging from $55.35 to $56.20. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 04, 2019 Filed Apr 8, 2019 17:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 8,600 | $38.55 | $331,530.00 |
DisclosureSEC source: 0001179110-19-004826 · edgar.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2019 Filed Apr 8, 2019 17:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 13,891 | $22.30 | $309,769.30 |
DisclosureSEC source: 0001179110-19-004826 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2019 Filed Apr 8, 2019 17:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,469 | $12.21 | $115,616.49 |
DisclosureSEC source: 0001179110-19-004826 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2019 Filed Mar 6, 2019 18:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003465 · edgar.xml · derivative · entry 7 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,713 Underlying: Common Stock · 1,856 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On May 25, 2017, the reporting person was granted 7,426 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. F6 · derivative.expiration_date: On May 25, 2017, the reporting person was granted 7,426 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. Read SEC document |
| March 06, 2019 Filed Mar 6, 2019 18:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 505 | $60.62 | $30,613.10 |
DisclosureSEC source: 0001179110-19-003465 · edgar.xml · nonDerivative · entry 4 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,986 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 06, 2019 Filed Mar 6, 2019 18:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,856 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003465 · edgar.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 18:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 5,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003465 · edgar.xml · derivative · entry 6 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,922 Underlying: Common Stock · 5,922 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 18:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 2,305 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003465 · edgar.xml · derivative · entry 5 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,609 Underlying: Common Stock · 2,305 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2018, the reporting person was granted 6,914 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On March 1, 2018, the reporting person was granted 6,914 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 18:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 846 | $67.55 | $57,147.30 |
DisclosureSEC source: 0001179110-19-003465 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,635 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 18:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,305 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003465 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 16:38 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,734 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-014139 · edgar.xml · derivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,734 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on December 18, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 16:38 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,734 | $50.01 | $136,727.34 |
DisclosureSEC source: 0001179110-18-014139 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,176 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 16:38 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,734 | $6.01 | $16,431.34 |
DisclosureSEC source: 0001179110-18-014139 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 16:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,202 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-013512 · edgar.xml · derivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,734 Underlying: Common Stock · 8,202 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on December 18, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 16:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 8,202 | $64.14 | $526,076.28 |
DisclosureSEC source: 0001179110-18-013512 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,176 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 16:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 8,202 | $6.01 | $49,294.02 |
DisclosureSEC source: 0001179110-18-013512 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,378 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 13:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,202 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001182489-18-000322 · edgar.xml · derivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,936 Underlying: Common Stock · 8,202 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on December 18, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 13:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 8,202 | $77.42 | $634,998.84 |
DisclosureSEC source: 0001182489-18-000322 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,176 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018. F2 · price: Represents the weighted average price of transactions ranging from $77.15 to $77.60. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 13:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 8,202 | $6.01 | $49,294.02 |
DisclosureSEC source: 0001182489-18-000322 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,378 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 03, 2018 Filed Jul 9, 2018 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,778 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-18-009559 · edgar.xml · derivative · entry 7 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,229 Underlying: Common Stock · 2,778 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| July 03, 2018 Filed Jul 9, 2018 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,841 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-18-009559 · edgar.xml · derivative · entry 6 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,831 Underlying: Common Stock · 2,841 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| July 03, 2018 Filed Jul 9, 2018 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,202 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-009559 · edgar.xml · derivative · entry 5 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,138 Underlying: Common Stock · 8,202 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vests as to 25% of the shares on December 18, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.